Viewing Study NCT05528406


Ignite Creation Date: 2025-12-26 @ 2:43 PM
Ignite Modification Date: 2025-12-26 @ 2:43 PM
Study NCT ID: NCT05528406
Status: UNKNOWN
Last Update Posted: 2022-09-06
First Post: 2022-09-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Clinical Trial to Evaluate HLX208 in Advanced Solid Tumor Patients With BRAF V600 Mutation
Sponsor: Shanghai Henlius Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module